HCG Diet HCG Weight Loss - New HCG Sublingual Tablets with B12

The Oral HCG diet we use at Perfect Skin Laser Center is easier and more convenient than the injections used by most clinics that offer the HCG diet. Dr. Bianca Munoz has trained directly with Dr. Daniel Belluscio of The Oral hCG Research Center, with over 30 years of clinical practice and scientific research. The Sunlingual Oral HCG Diet combines a natural hormone with a low calorie diet to stimulate your body to burn fat while preserving muscle. Compared to other diets the HCG diet immeditely begins to burn fat off your body and does it with out you feeling hungry or tired. The results are amazing and fast. Men can lose a pound a day and women typically lose a half a pound a day.

Perfect Skin Laser Center is one of the leading founders of aesthetic medicine in Arizona.  Our doctors have striven to provide the highest quality of care for our patients.  Our physicians create individualized programs to help our patients achieve their goals.  Perfect Skin Laser Center is dedicated to finding the best treatments with the highest safety and efficacy. 

With the growing popularity of the HCG diet protocol many non-medical based establishments and/or improperly educated health professionals are erroneously distributing the HCG Diet.  Our physicians have elected to seek further training from well-established clinics and physicians to provide the highest level of care for our patients. 

There is a lot of misinformation about the hCG diet that is being disseminated into the general public by uneducated practitioners.  We at Perfect Skin Laser Centers highly recommend an individual consultation with Dr Bianca Munoz to best answer all of your questions directly and ascertain if this particular weight loss protocol is appropriate for your needs and your current health.

What is hCG?

Natural, yet effective.
hCG is the acronym for Human Chorionic Gonadotropin, a substance produced by the placenta during pregnancy in huge amounts. It was discovered by Ascheim and Zondek in the urine of pregnant women, back as 1927.

After its discovery, scientists tried to find a name for this substance, and when they observed that the administration of hCG helped to provoke ovulation in experimentation animals, they named their discovery Gonadotropin, that means it has an action on gonads (testicles or ovaries) and Chorionic because later it was found was produced by the Chorium of the placenta.

hCG is one of the few drugs of natural origin that still remain in the current Pharmacopoeia. Secreted by the placenta, the presence of hCG in the urine of pregnant women was first reported by Ascheim and Zondek in 1927. Since then, thousands of scientific articles have been published about the effect of hCG on gonads (testicles or ovaries), but comparatively a small number of these have investigated its vast therapeutic potential on diseases ranging from Kaposi sarcoma, to asthma, psychoses, artheriopaties, thalassemia, osteopenia, alcoholism, glaucoma, and cancer.

Large quantities of hCG are secreted by the placenta during pregnancy, invalidating claims of cancer or hirsutism (disproportionate hair growth) as side effects of HCG, as no clinical records exist of pregnant women being more susceptible to these diseases.

Research done by Dr. Daniel Belluscio at the Oral hCG Research Center has determined that the use of hCG diet for obesity treatment meets patients' expectations for a safe and effective weight loss program that is easy to follow and can improve their quality of life, without negative side effects or contraindications.

Use of hCG for treatment of obesity and overweight.

The first report on the use of the hCG diet was published in 1954 by the late Dr. ATW Simeons, a German-born physician practicing at the Ospedale Salvatori Mundii in Rome.
In India males who suffered from a condition called Adiposogenital dystrophy where the testes are un-descended, improved in their symptomology when they were treated with hCG. Part of their symptomology that improved was a re-distribution of fat from the abdomen, hips, and thighs to an appropriate and health distribution. Therefore, Dr. Simeon hypothesized that if those children were concomitantly submitted to a very low calorie diet they could further reduce their body weight, consuming the “abnormal fat”.
Later on, he extended his investigations to patients showing different degrees of obesity, and concluded that hCG might be useful for the treatment of obesity because:
• Patients tolerated a Very Low Calorie Diet (VLCD) without suffering headaches, irritability and weakness, so common to this approach for weight reduction.
• Maintenance period after treatment was more effective when compared with simple dietetic procedures.
• Weight reductions were more satisfactory than those obtained with Standard VLCD.
• Patients lost more body fat (measured in centimeters) from those regions where adipose tissue accumulations were more conspicuous.
He hypothesized that hCG acted at diencephalic level, a part of the brain that modulates the hypothalamic regulatory centers, which were in turn responsible for the excessive fat accumulation as seen in obesity.
For many years the hCG diet for weight loss enjoyed worldwide popularity due to the excellent obtained results. Daily administration of very small doses of hCG plus a Very Low Calorie Diet (VLCD) rapidly decreased body weight without any side effects. Hundreds of thousands of patients benefited from this safe and effective weight reduction program.
Obesity has now reached worldwide proportions, and society faces a problem that will cause more suffering, disease and death than any other plague over the last three hundred years. The use hCG may well be a safe and effective alternative for treating those millions of individuals suffering obesity.

How does hCG help you lose weight in all the right places?

It’s not only about pounds; it’s also about the inches
.
The original hCG diet consists of a combination of a Very Low Calorie Diet and the use of hCG via injections. However, the amount of weight lost during treatment does not differ significantly from other treatments involving low calorie diets.
What makes treatment with hCG so effective is that patients lose significantly more body fat than patients that only diet. The impact is seen in a changed body contour, with particular impact on those hard to reduce areas such as thighs and buttocks.

Eliminating the Rebound effect with the hCG diet.

Fat gains “weight” faster than muscle, this is a known fact. So when you change the proportion of body fat to muscle in your body during treatment with the hCG diet you are actually diminishing your chances of rebounding back to your original weight.
Once the treatment with low calorie diet ends (approximately four weeks, depending on the weight loss objective) patients go through a “maintenance” period where the level of calories is restored to the usual rate according to body type, but all ingredients that could be stored by the body as fat are restricted. In this way, the body realigns itself to a normal eating routine, but does not increase the fat storage, which greatly diminishes the risk of rebounding back to the original weight.
During treatment you will quickly lose weight, but maintain your muscle mass, and the weight loss will be concentrated in those areas that are most complicated and difficult to reduce.

The hCG Diet for the treatment of obesity:

Overcoming the "test of time"
Author: Daniel Oscar Belluscio, MD
"A new scientific truth does not triumph by convincing its opponents and making them see the light, but rather because its opponents eventually die, and a new generation grows up that is familiar with it."
Max Planck 1858-1947. German Theoretical Physicist

A. The pharmacological nature of hCG
B. A word of caution for those interested in the hCG method for obesity treatment.
C. Proposed mechanisms of action
D. An interesting combined procedure: hCG protocol plus selective local adrenergic modulation of adipose tissue metabolism
E. Oral hCG (Human Choriogonadotropin) for the management of obesity: a Double-Blind study
Note: The number in bold and between brackets refer to the bibliographical references included in the double-blind study.

A. The pharmacological nature of hCG

hCG is a glycoproteic hormone, normally secreted by trophoblastic cells of the placenta. It consists of two dissimilar, separately but coordinately translated chains called the Alpha and Beta subunits (46-93-160-231-369-415-483-484).
The three pituitary hormones LH (Luteinising Hormone) are closely related to hCG in that all four are glycosylated and have a dimeric structure comprising an Alpha and Beta chain as well.
The aminoacid sequences of the Alfa chain of all four human glycoproteic hormones are nearly identical.
Aminoacid sequences of the beta subunits differ because of the unique immunological and biological activities of each glycoproteic hormone. Beta -hCG contains a carboxylic residue of 30 aminoacids characteristic to hCG (44-45-216-395).
When it was discovered by Ascheim and Zondek by 1927 they found out that hCG matured the infantile sex glands of experimental animals, and it was secreted by the human placenta. From there its denomination: Chorionic Gonadotrophin (25-519).
However, recent data suggest that both terms can be quite misleading: normal human tissues (231-464) plasma from non pregnant subjects (62-353-516), trophoblastic and non-trophoblastic tumors (83 -106- 110- 226-345- 400-401-444), bacteria (3- 4- 28- 301- 312-436) and plants (138-168) express hCG or a hCG- like material.
After the first report on hCG use for obesity treatment, an innumerable amount Physicians all over the world visited Dr. Simeons in Italy, to learn from first hand the hCG original protocol.
Many of them attempted to recreate the standard procedure without success, or obtaining undesirable results.

B. A word of caution to those interested in performing the method.

After many years of experience on the use of hCG for the management of obesity, we would like to stress the following

• hCG is not a magic wand
It does not cure or eradicate obesity, but weight losses are rapid, comfortable, and the maintenance period after treatment runs a smoother course.

• There is no difference regarding weight loss between hCG-treated and
non-treated patients

Obesity might not be only a matter of overweight. Dieting per se is not a treatment for obesity. Rather, it is an ancillary procedure.
Unless we try to act upon the basic diencephalic disturbance, any dietetic procedure will be condemned to failure.
We cannot improve diabetes just by dieting, and obesity cannot be effectively treated without some sort of medical intervention in the diencephalon.
Anorectics point in that direction, and were for many years an unsuccessful approach to obesity because their side-effects.
Dr. Simeon never sustained that weight loss under hCG was more important than without hCG-treated cases. What he suggested was that hCG, acting at hypothalamic level, might correct the basic hypothalamic disorder, and consequently adipose tissue metabolism.
If this turns out to be the case, hCG could be an excellent adjuvant procedure in the management of the disease.
The vast majority of publications concluded hCG has no action on weight loss, rendering no better results than a current Hypocaloric diet, except for classical Asher and Harper report concluding that weight losses under hCG were superior to placebo.

C. Proposed mechanisms of action

• hCG displays a metabolic action on adipose tissue metabolism

Throughout these years, hCG has been reported to exert its actions on several tissues other than gonadal: Kaposi sarcoma, asthma, psychoses, artheriopaties, thalassemia, osteopenia, alcoholism and glaucoma. Therefore, we are not dealing with a "pure" sex hormone
Available data would indicate that hCG might also improve lypolisis in human adipose tissue, via an inhibitory effect on lipogenesis.


• hCG actions on adipose tissue metabolism (161-382)

Fleigelman concluded that the administration of hCG in rats decreased the activity of alpha-glycerophosphate dehydrogenase and glucose-6-phosphate dehydrogenase from the liver and adipose tissue, suggesting a decreased lipogenic activity in both tissues under hCG (161) .

Yanagihara reported that hCG accelerates "not only the mobilization of fat from fat deposits, but also its utilization in peripheral tissues. hCG increased the metabolism of injected fat emulsions, suggesting the acceleration not only of fat oxidation, but also increased ketone production in the liver and its utilization in peripheral tissues" (514).
Romer reported that hCG intensifies the metabolism of rat brown adipose tissue (391).
Administration of hCG to humans appears to increase the release of fatty acids that varies with the age of the subject. Melichar demonstrated that hCG causes a marked FFA release in newborn infants (317).
In adults, a single dose of hCG caused a marked FFA release by p > 0.05 when compared to placebo-treated subjects.
Consequently we hypothesize, that hCG might act upon adipose tissue metabolism through some mediators secreted at hypothalamic level.


• The diencephalic region and hCG

One of the most valuable hypotheses on the genesis of obesity sustains that the basic metabolic disorder lies in the hypothalamic region: like in any other clinical disorder, we have to find out who is the villain in this story. For example: the pancreas in diabetes, the thyroid in hypothyroidism. the adrenal glands in Addison disease.
The organ more frequently incriminated in the genesis of fat accumulation seems to be the hypothalamus. A considerable body of evidences points in that direction.
Interestingly, exogenous administered hCG accumulates in hypothalamic region, particularly in Ventromedial and Lateral Hypothalamus. It is not therefore unreasonable to suppose that the target organ for hCG metabolic actions might be the diencephalon. (178-513)
hCG may act at diencephalic level, probably modifying some neuropeptide metabolic pathways, which in turn act whether on Ventromedial or Lateral hypothalamic Nucleus, or via Hypothalamus hypophisis (30-209).

Summary

There are no age or sex limits, and hardly any contraindications (211) to use the hCG method for the treatment of obesity. Tolerance to the treatment is excellent, and many patients willingly submit to a second treatment.
Weight loss is safe and comfortable for patients, provided that they meticulously follow the prescribed diet. Any deviation from the protocol is apt to yield poor results. Even minor deviations may cause unwanted setbacks.
The hCG diet is an appropriate approach to the treatment of obesity that also includes a behavior modification program as well as pharmacological and dietetic aspects. When properly managed, the result is rapid weight loss and improved body shape after treatment. Clinical complications and unfavorable results are related to unsafe modifications of the protocol.
Evidence suggests that hCG promotes lipolytic activity. Since hCG does not mobilize in vitro lipids from the fat cell, it was hypothesized that the hypothalamic region might be the intermediate organ in hCG lipolytic action.
The classic hCG method includes patients' follow-up (daily visits to the doctor to be weighed and injected), helping patients with their behavior modification program. There are some similarities between the behavioral program included in the hCG diet and a current behavior modification program for obesity treatment.
The 500 Kcal-diet as prescribed in the original treatment proved to be safe and effective. Results are not surpassed by any other modality of obesity therapy. Reshaping of body contour is more noticeable in those patients displaying the so-called gynoid types (fat located in buttocks and hips area). TOP

D. An interesting combined procedure: hCG protocol plus selective local adrenergic modulation of adipose tissue metabolism

• Introduction

The subject of adipose tissue membrane receptors has been a subject of great interest in recent years.
Human fat cells possess both Alpha and Beta membrane adrenoreceptors, acting differently on adipose tissue metabolism (500).

The major function of adrenoreceptors in white fat cells is to regulate the breakdown of triglycerides to free fatty acids and glycerol through lipolysis. Functions and mechanisms of action of adrenoreceptors in white fat cells are as follows:(16-17-18-19-20-21-22).

1. Beta l.2.3. receptors increase lipolysis rate.

2. Alpha 2 decrease lipolysis rate.

Human adipose tissue is an extremely metabolic active organ: Depending on where it is localized, it shows a different response to drug intervention. Visceral fat cells are more responsive than abdominal subcutaneous fat cells (gluteal or femoral) to the lipolytic actions of catecholamines.
There are also sex differences: A higher Alpha2-receptor affinity has been reported in peripheral male subcutaneous fat cells than in the abdominal, which may explain why the regional variation in catecholamines-induced lipolysis within the subcutaneous adipose tissue is more pronounced in men than in women.
Fasting also modifies the regional sensitivity of adipose tissue: It is associated with a decrease in catecholamines-induced lipolysis rate in peripheral, but not abdominal, subcutaneous adipose tissue. This may further promote the development of gynoid obesity.
During fasting, Alpha activity (antilipolytic) increases and Beta action (lipolytic) decreases in female thighs region (351-352).
An increase of Alpha activity is related to a decreased lipolysis, whereas a diminution of beta adrenergic activity provokes the same effect (366).
Therefore, it has been suggested that the combination of both activities might explain why the female thigh region is more resistant to dietetic procedures.
Abdominal adipocytes are more responsive to the lipolytic action of Beta-1 adrenergic agonists, while gluteal adipocytes are more responsive to the antilipolytic action of Alpha-2-adrenergic agonists.
In lean and obese adults, gluteal subcutaneous adipose tissue was strikingly more responsive to antilipolytic alpha-adrenergic stimulation, and less responsive to lipolytic beta-adrenergic stimulation compared to abdominal tissue (394).
This would explain why gluteal and femoral fat pads are more resistant to dietary interventions.
Taken together, these results seem to suggest that it should be possible to locally modulate the activity of Alpha and Beta adrenoreceptors through the administration of Beta-adrenergic or Alpha-Blockers agents. Beta Stimulation and/or Alpha blocking of adipocytes membrane receptors might increase lipolysis in those areas.
Thus, a reasonable combination would be the prescription of a Very Low Calorie Diet (such as indicated in the hCG Protocol) plus the local administration of Alpha Blockers or Beta stimulating agents.
We have found the association of both procedures extremely useful, both from the Clinic as well as from the Aesthetic viewpoint.


The controversy over hCG diet.

Why is hCG not approved for Obesity treatment by the FDA
(Food and Drug Administration)?

After Dr. Simeon’s first published reports of his protocol for use of hCG in the treatment of obesity, this preliminary communication was followed by a myriad of reports, some of them favoring the use of hCG, and others criticizing the procedure.
Finally, and after a serial of Double-Blind Tests, the FDA concluded the method bears no utility for Obesity therapy.
This Administration forced Pharmaceutical Firms to include in their hCG leaflets of information a paragraph stating that hCG was of no use in the management of obesity.
FDA parameters for approving drugs for obesity treatment specify that more weight should be lost with use of drug vs. placebo. And as we have stated, the use of hCG as indicated in Dr. Simeon’s protocol does not result in more pounds lost vs. placebo, but does generate a considerable difference in fatty deposits.


Quantity vs. Quality

While the FDA continues to maintain that hCG is of no use in the management of obesity, experience in patients throughout the years has proven that weight loss and the quality of weight loss (reduction of fat) is more effective while using hCG.

The Interests of the pharmaceutical Industry:

hCG is not open to Patent, and this is its major draw back in terms of business gain for pharmaceutical companies. The Oral hCG Method™, developed by Dr. Belluscio, is a patent pending utility belonging to the Oral hCG Research Center and is composed of a series of procedures, one of which is the administration of hCG.
However, while understanding and knowledge of the treatment is restricted to licensed professionals, the medication as such does not represent an area of economic interest for laboratories.

The Oral hCG Diet

Treatment Plans.

All of our Oral hCG™ Diet Programs are tailor-made: our physicians design an Oral hCG™ Diet Program according to your requirements. Our physicians prepare your diet plan according to your preferences and the food available in your area.
In order to undergo the Oral hCG™ diet, it is necessary for you to come to The Oral hCG Treatment Center in Arizona and stay at least for 7 to 10 days to get you started on the treatment. Accomodations may be made for out-of-state patients, please discuss your individual situation with your physician directly.
Due to numerous received requests regarding aspects of the Oral hCG™ protocol for weight loss workshops, here follows some clarifications:

Our Center
You can arrive at any given time: we're open through the year.
We are located in Tempe and Scottsdale, Arizona, and our Center is an outpatient one, so we don't provide accommodation to patients.

Meals
In Tempe and Scottsdale, Arizona there are plenty of meat and groceries stores, all organic. 

Payment method
The balance of the treatment must be paid in full by the 1st day of treatment.  Specific laboratory tests may be required by your physician prior to starting the program and a down-payment of 20% may be collected at the time to secure your follow-up appointment.  Various financial payment services are available; please discuss your options with the general staff at Perfect Skin Laser Centers.

Note:
• We do not endorse any claim regarding the use of Oral hCG™ for obesity treatment (an approach developed by Daniel Oscar Belluscio MD), except those issued by our Institution.
• When undergoing the Oral hCG™ protocol, you must not discontinue any medication prescribed by your Physician.

Oral vs. Injectable

The Oral HCG™ Method: Same effectiveness, no injections.

Dr. Simeons method of hCG combined with a low calorie diet has proven to be highly effective in patients worldwide. However, the development of and oral formulation of hCG transforms the experience, eliminating the need for constant injections, which can result in an uncomfortable process.
The Oral hCG Research Center has conducted a clinical trial using Oral hCG™ in lieu of injectable hCG, and has obtained the same positive results.
The Oral HCG™ Method developed by Dr. Daniel Belluscio maintains a strict adherence to the original protocol developed by Dr. Simeon, and is an integral method that addresses the physical and emotional impact of obesity and gives an answer to both.
There are no age or sex limits, and hardly any contraindications to use the Oral HCG™ Method for the treatment of obesity. Tolerance to the treatment is excellent, and many patients willingly submit to a second treatment to continue their weight loss process.
Weight loss is safe and comfortable for patients, provided that they meticulously follow the prescribed diet. Any deviation from the protocol is apt to yield poor results. Even minor deviations may cause unwanted setbacks.
The Oral hCG™ protocol is an appropriate approach to the treatment of obesity that also includes a behavior modification program as well as pharmacological and dietetic aspects.
When properly managed, the result is rapid weight loss and improved body shape after treatment. Clinical complications and unfavorable results are related to unsafe modifications of the protocol.
The Oral hCG™ Method includes patients' follow-up, helping patients with their behavior modification program.
The 500 Kcal-diet as prescribed in the original treatment proved to be safe and effective.
Results are not surpassed by any other modality of obesity therapy. Reshaping of body contour is more noticeable in those patients displaying fat located in buttocks and hips area.
Advantages of The Oral hCG™ Method


No bad moods. No headaches. No weakness.
Drastically reducing your caloric intake almost necessarily brings unwanted side effects. Irritability, headaches and feelings of weakness are the most common of these side effects, and these side effects make it almost impossible for most people to maintain the discipline a low calorie diet requires, even if the weight loss is great.
The use of Oral hCG™ during treatment not only affects where you lose weight, but also how you feel while doing it.
hCG is believed to generate endorphins in the human body, and these endorphins generate feelings of well being, increased energy and increase your ability to focus, making the Oral hCG Method ™ not only effective in its results, but also in its process.
During treatment with Oral hCG™, you will be able to continue an active lifestyle, including exercise (although exercising is not a condition for achieving results). You will feel energized and in good moods, and will not experience hunger pangs.

The advantages of the Oral hCG™ Diet can be summarized in the following points:

Speed: The Oral hCG™ diet delivers an average weight loss of 8 kilos every four weeks (17.6 lbs), with no recovery of weight in the period following treatment. This speed allows patients to visualize results almost immediately, acting as a strong motivator to strictly adhere to the treatment.

Focused weight loss and modeling of body contour: The Oral hCG™ diet delivers important weight loss, but as a differentiating factor vs. other weight loss treatments using Very Low Calorie Diets (VLCDs), most of the weight loss is concentrated on localized subcutaneous fat, particularly in those areas where there is greater concentration. Structural fat, necessary to maintain a healthy body and muscular mass is not affected: As a consequence, the proportion of body fat to muscle changes radically, making the metabolic process more efficient and reducing possibilities of the well known “rebound effect.” Additionally, a positive effect is produced on skin tissues, which become more elastic and accompany the loss in body weight, assuring a harmonious corporal contour. Loose, sagging skin is not evidenced, even when weight loss is notorious (more than 20 kilos.)

No secondary side effects: The use of hCG has not demonstrated negative side effects in any of its approved utilities, nor in use with the Oral hCG™ diet. Additionally, double blind studies and clinical results of patients undergoing treatment with Oral hCG™ have shown that patients present high levels of energy, good mood, absence of headaches, and lack of hunger and anxiety.

Constant Medical Supervision: The Oral hCG™ Diet insures patients a continuous follow up and supervision by a trained medical professional. The possibility of constant exchange with the medical professional helps patient motivation and allows them to maintain a constant course of treatment, increasing effectiveness. Because hCG is a prescription medicine, all treatments with hCG should be supervised by a licensed physician.

Reduction of arterial pressure, blood sugar, cholesterol and lipodystrophies: Because weight loss is concentrated in abnormal fatty deposits, treatment under the Oral hCG™ diet delivers increased reduction of risk factors associated to obesity and overweight in patients.

Importance of Medical Supervision

Responsibilities of Health Care Professionals
It is with great concern that we are seeing a continual growth in the self administration of the hCG protocol for weight loss. In our experience, and in the experience of all medical professionals involved with the hCG diet, including Dr. Simeon himself, the rate of success in patients that are not supervised during treatment is considerably lower than those who are supervised by a physician that adheres strictly to the protocol set out by Dr. Simeon.
It is the responsibility of health care professionals to supervise, advise, guide and control patients health before, during and after treatment. The physician should be able to establish which patients are good candidates for treatment with hCG, and together with their patient set realistic expectations that will allow for a successful process.
The supervising physician should ideally be trained in the Simeon protocol, and have a strong focus on this modality. The hCG protocol for weight loss is complex and exhaustive, and only a strict adherence brings the results we have exposed in other areas of this web page.
Please be advised, that hCG is a prescription drug. Its administration must be prescribed and supervised by a licensed Physician. Your physician will also be able to insure that the quality of hCG that you receive is optimal, as there are many different qualities available in the market.
When undergoing the hCG protocol, you must not discontinue any medication prescribed by your Physician.

In Dr. Simeons words:
The hCG + diet method can bring relief to every case of obesity, but the method is not simple. It is very time-consuming and requires perfect cooperation between physician and patient.
Each case must be handled individually, and the physician must have time to answer questions, allay fears and remove misunderstandings. He must also check the patient daily.
When something goes wrong he must at once investigate until he finds the reason for any gain that may have occurred. In most cases it is useless to hand the patient a diet-sheet and let the nurse give him "a shot".

Dr. ATW Simeons
The action of Chorionic Gonadotrophin in the obese
Lancet. 1954 Nov 6;267(6845):946-7

We are aware that many patients have been using Dr. Simeon book “Pounds and Inches” as a guide to self administer treatment. We would like to remind you of his opening words:

“I must warn the lay reader that what follows is mainly for the treating physician and most certainly not a do-it-yourself primer.
Many of the expressions used mean something entirely different to a qualified doctor than that which their common use implies, and only a physician can correctly interpret the symptoms which may arise during treatment. (*)
Any patient who thinks he can reduce by taking a few shots and eating less is not only sure to be disappointed but may be heading for serious trouble. (*)

The benefit the patient can derive from reading this part of the book is a fuller realization of how very important it is for him to follow to the letter his physician's instructions. In treating obesity with the hCG + diet method we are handling what is perhaps the most complex organ in the human body.
The diencephalon's functional equilibrium is delicately poised, so that whatever happens in one part has repercussions in others. In obesity this balance is out of kilter and can only be restored if the technique I am about to describe is followed implicitly.

Even seemingly insignificant deviations, particularly those that at first sight seem to be an improvement, are very liable to produce most disappointing results and even annul the effect completely. (*)

For instance, if the diet is increased from 500 to 600 or 700 Calories, the loss of weight is quite unsatisfactory. If the daily dose of hCG is raised to 200 or more units daily its action often appears to be reversed, possibly because larger doses evoke diencephalic counter-regulations. (*)

On the other hand, the diencephalon is an extremely robust organ in spite of its unbelievable intricacy. From an evolutionary point of view it is one of the oldest organs in our body and its evolutionary history.”
POUNDS AND INCHES
A New Approach to Obesity
BY A.T.W. SIMEONS M.D.
SALVATOR MUNDI INTERNATIONAL HOSPITAL
00152 - ROME VIALE MURA GIANICOLENSI, 77
ALL RIGHTS RESERVED
PRINTED IN ITALY

Impact of Medical Supervision on Results
As stated previously, medical supervision is key in order for patients to obtain optimal results using hCG. In 1973 Dr. W.L. Asher and Dr. Harold W. Harper published the results of a double blind study aimed to evaluate the effects of hCG on weight loss, hunger and feeling of well-being in the American Journal of Clinical Nutrition.
The results obtained described an increased weight loss in patients undergoing treatment with hCG vs. placebo. More importantly, there were significant differences in terms of lack of hunger and increased feelings of well-being. Patients with hCG were more consistent in their adherence to the diet and were able to complete the course of treatment more successfully. These double blind studies were performed under supervision of physicians strictly following indications as set out in the Simeon protocol.
Dr. Asher and Dr. Harper then replicated the same study, this time on patients that were supervised by physicians, but using Simeons’ programs modified to varying degrees. The physicians had little or no experience with the protocol, and none of the programs considered the rigidness of the original plan. One physician allowed patients to self administer hCG injections at home, and diets, although respecting the caloric intake, were not strict as to the ingredients allowed.
Results of this experience were surprisingly negative. Drop out rate was significantly higher than those experienced in the previous study. Weight loss showed no difference between hCG and placebo treated patients, and in some cases were even below those achieved by placebo treated patients under strict supervision.
It is clear that the success of hCG for weight loss is strictly linked to medical supervision and strict adherence to the medical protocol designed by Dr. Simeon.
**scientific research studies are available upon request**

**this information is taken from Dr. Belluscio’s website an expert on the HCG Diet with whom Dr Bianca trained.**

2177 E Warner Rd STE 105 Tempe, AZ 85284

7045 E 3rd Ave Scottsdale AZ 85251